MCM
PRAH

Manchester Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Manchester Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3
Closed – – 828
2020
Q4 		$0 Hold
3
– – ﹤0.01% 803
2020
Q3 		$0 Buy
+3
New +$306 ﹤0.01% 705
2019
Q2 		– Sell
-521
Closed -$57K – 669
2019
Q1 		$57K Buy
+521
New +$54.4K 0.01% 383

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Manchester Capital Management's PRAH Position: Q1 2021 in Review

Manchester Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 3 shares.

Manchester Capital Management first reported a position in PRAH in Q1 2019 and held it in 3 quarters. The position peaked at $57K in Q1 2019. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Manchester Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Manchester Capital Management sold 3 PRA Health Sciences, Inc. shares in Q1 2021.
  • Manchester Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2019 and held it in 3 quarters.
  • Manchester Capital Management's PRA Health Sciences, Inc. position peaked at $57K in Q1 2019.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Manchester Capital Management's 13F filing for Q1 2021, filed 13 May 2021.